Health
newsGP – ‘Important’ study shows gout medication can halt coronary disease progression – RACGP
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
News
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
Coronary heart disease is the leading cause of death in Australia.
The international study, published in The New England Journal of Medicine, examined the effect of low dose colchicine in patients with chronic coronary disease who were already taking established treatments.The two-year randomised, controlled, double-blind trial, led by GenesisCare i…
-
Noosa News15 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General19 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General8 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
General18 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba